We are 225,786 members in 82 forums discussing 158,452 topics.

Help with Abbreviations

Topic: Immunotherapy Tecentriq Only Effective in PD-L1+ BC

Forum: Immunotherapy - Before, During, and After —

Discuss your experiences with the benefits, risks, and side effects of immunotherapy treatment for breast cancer.

Posted on: Dec 18, 2018 12:21PM

Moderators wrote:

New Analysis Shows Immunotherapy Tecentriq Only Effective in PD-L1-Positive Breast Cancer
December 14, 2018

A new analysis of the IMpassion130 trial found that the immunotherapy Tecentriq (chemical name: atezolizumab) in combination with the chemotherapy Abraxane (chemical name: albumin-bound paclitaxel or nab-paclitaxel) only helps treat cancers that are PD-L1-positive. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply